Interim Chief Medical Officer
Septerna 250 East Grand Avenue, Suite 65 South San Francisco, CA 94080
About Us
Real Team.
Real Purpose.
Our StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur Story
Our StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur Story
Our Story
Our mission is to discover, develop, and commercialize medicines that improve the lives of patients by combining the potential of high-value GPCR drug targets with the power of state-of-the-art small molecule drug discovery technologies. Septerna’s Native Complex™ Platform is the engine that will make this happen, moving ideas for disease-modifying therapies from possibility to reality.
Septerna has assembled a team that thrives on innovation, combining pioneering GPCR scientists with experienced drug hunters. Our founders have made seminal discoveries that reveal the inner workings of GPCRs and how they control physiology. Our scientists have built upon these unique insights to develop our industrial-scale Native Complex™ Platform.
We are focusing the Native Complex™ Platform on tackling previously difficult-to-drug GPCR targets, and our small molecule drug discovery efforts have rapidly advanced, resulting in a pipeline of innovative programs. With an unprecedented level of productivity, we are setting the stage for a new future for GPCR-targeted medicines.
Our TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur Team
Our TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur Team
Our Team
Leadership 
Alan Ezekowitz, MD, DPhil
Ali Masoudi, PhD
Protein Sciences
Amer M. Mirza, PhD
Vice President, Disease Biology and Translational Sciences
Andres Perez Rivas
Protein Sciences
Ariel Wein, PhD
Protein Sciences
Chia-Hung Tai
Discovery Biology
Chris Heise, PhD
Vice President, Discovery Biology
Daniel Long, DPhil
Senior Vice President, Drug Discovery
Dean P. Staus, PhD
Protein Sciences
Elyas Kefela
Operations
Evan Green, PhD
Protein Sciences
George Xu, PhD
Director, Corporate Strategy & Portfolio Development
Jasleen Sodhi, PhD
DMPK
Jeffrey Finer, MD, PhD
Chief Executive Officer and Co-founder
Jialu Wang, PhD
Protein Sciences
Jun Zhang
Disease Biology
Kathryn Luderman, PhD
Discovery Biology
Ken Eng
Human Resources
Kris Dalmacio
Operations
Liz Bhatt, MS, MBA
Chief Operating Officer
Matthew Volgraf, PhD
Medicinal Chemistry
Mel Manalo, MSc, PMP
Technology
Michael Broeker
Operations
Michael Wong
Protein Sciences
Miles Yamasaki
Protein Sciences
Ran Xiao
Vice President of Finance and Business Operations
Richard Hansen, PhD
Vice President, Technology
Richard van Rijn, PhD
Disease Biology
Robert Keyser
Technology
Ryan Muir, PhD
Discovery Biology
Ryan Strachan, PhD
Discovery Biology
Steve McKerrall
Medicinal Chemistry
Uwe Klein, PhD
Senior Vice President, Biological Sciences
Victoria Wu, PhD
Disease Biology
Xiang Zhou, PhD
Medicinal Chemistry
Xiaohui Du, PhD
Medicinal Chemistry
Our Teams
Leadership
Robert Lefkowitz, MD
Duke University, HHMI
Arthur Christopoulos, PhD
Monash University
Patrick Sexton, PhD, DSc
Monash University
Jeffrey Finer, MD, PhD
Chief Executive Officer and Co-founder
Investors
Join Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our Team
Join Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our Team
Join Our Team
Join our growing team of experts